nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Abdominal pain—Thiotepa—sarcoma	0.00158	0.00158	CcSEcCtD
Gemifloxacin—Body temperature increased—Thiotepa—sarcoma	0.00158	0.00158	CcSEcCtD
Gemifloxacin—Leukopenia—Etoposide—sarcoma	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Body temperature increased—Dactinomycin—sarcoma	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Abdominal pain—Dactinomycin—sarcoma	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Loss of consciousness—Etoposide—sarcoma	0.00154	0.00154	CcSEcCtD
Gemifloxacin—Decreased appetite—Vincristine—sarcoma	0.00154	0.00154	CcSEcCtD
Gemifloxacin—Dyspnoea—Mitoxantrone—sarcoma	0.00154	0.00154	CcSEcCtD
Gemifloxacin—Somnolence—Mitoxantrone—sarcoma	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Blood creatinine increased—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Vincristine—sarcoma	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Fatigue—Vincristine—sarcoma	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Hyponatraemia—Doxorubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Gemifloxacin—Dyspepsia—Mitoxantrone—sarcoma	0.00152	0.00152	CcSEcCtD
Gemifloxacin—Pain—Vincristine—sarcoma	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Constipation—Vincristine—sarcoma	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Decreased appetite—Mitoxantrone—sarcoma	0.0015	0.0015	CcSEcCtD
Gemifloxacin—Fatigue—Mitoxantrone—sarcoma	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Breast disorder—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Gemifloxacin—Pain—Mitoxantrone—sarcoma	0.00147	0.00147	CcSEcCtD
Gemifloxacin—Constipation—Mitoxantrone—sarcoma	0.00147	0.00147	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Gemifloxacin—Face oedema—Doxorubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Vincristine—sarcoma	0.00145	0.00145	CcSEcCtD
Gemifloxacin—Gastritis—Epirubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Etoposide—sarcoma	0.00143	0.00143	CcSEcCtD
Gemifloxacin—Asthenia—Thiotepa—sarcoma	0.00143	0.00143	CcSEcCtD
Gemifloxacin—Asthenia—Dactinomycin—sarcoma	0.00142	0.00142	CcSEcCtD
Gemifloxacin—Blood creatinine increased—Doxorubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Gemifloxacin—Dysphagia—Epirubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Gemifloxacin—Pruritus—Thiotepa—sarcoma	0.00141	0.00141	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00141	0.00141	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Etoposide—sarcoma	0.0014	0.0014	CcSEcCtD
Gemifloxacin—Tachycardia—Etoposide—sarcoma	0.0014	0.0014	CcSEcCtD
Gemifloxacin—Eosinophilia—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Gemifloxacin—Abdominal pain—Vincristine—sarcoma	0.0014	0.0014	CcSEcCtD
Gemifloxacin—Body temperature increased—Vincristine—sarcoma	0.0014	0.0014	CcSEcCtD
Gemifloxacin—Skin disorder—Etoposide—sarcoma	0.00139	0.00139	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Etoposide—sarcoma	0.00139	0.00139	CcSEcCtD
Gemifloxacin—Pancreatitis—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Gemifloxacin—Urticaria—Mitoxantrone—sarcoma	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Breast disorder—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Anorexia—Etoposide—sarcoma	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Diarrhoea—Thiotepa—sarcoma	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Abdominal pain—Mitoxantrone—sarcoma	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Body temperature increased—Mitoxantrone—sarcoma	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Diarrhoea—Dactinomycin—sarcoma	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Gastritis—Doxorubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Gemifloxacin—Dizziness—Thiotepa—sarcoma	0.00132	0.00132	CcSEcCtD
Gemifloxacin—Dysphagia—Doxorubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Gemifloxacin—Eosinophilia—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Epirubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Gemifloxacin—Pancreatitis—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Gemifloxacin—Dyspnoea—Etoposide—sarcoma	0.00128	0.00128	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Gemifloxacin—Somnolence—Etoposide—sarcoma	0.00127	0.00127	CcSEcCtD
Gemifloxacin—Asthenia—Vincristine—sarcoma	0.00127	0.00127	CcSEcCtD
Gemifloxacin—Vomiting—Thiotepa—sarcoma	0.00127	0.00127	CcSEcCtD
Gemifloxacin—Pneumonia—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Gemifloxacin—Infestation—Epirubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Gemifloxacin—Infestation NOS—Epirubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Gemifloxacin—Vomiting—Dactinomycin—sarcoma	0.00126	0.00126	CcSEcCtD
Gemifloxacin—Rash—Thiotepa—sarcoma	0.00126	0.00126	CcSEcCtD
Gemifloxacin—Dermatitis—Thiotepa—sarcoma	0.00126	0.00126	CcSEcCtD
Gemifloxacin—Headache—Thiotepa—sarcoma	0.00125	0.00125	CcSEcCtD
Gemifloxacin—Rash—Dactinomycin—sarcoma	0.00125	0.00125	CcSEcCtD
Gemifloxacin—Decreased appetite—Etoposide—sarcoma	0.00125	0.00125	CcSEcCtD
Gemifloxacin—Renal failure—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Etoposide—sarcoma	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Asthenia—Mitoxantrone—sarcoma	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Fatigue—Etoposide—sarcoma	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Stomatitis—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Gemifloxacin—Pain—Etoposide—sarcoma	0.00123	0.00123	CcSEcCtD
Gemifloxacin—Constipation—Etoposide—sarcoma	0.00123	0.00123	CcSEcCtD
Gemifloxacin—Diarrhoea—Vincristine—sarcoma	0.00121	0.00121	CcSEcCtD
Gemifloxacin—Haematuria—Epirubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Gemifloxacin—Nausea—Thiotepa—sarcoma	0.00119	0.00119	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Diarrhoea—Mitoxantrone—sarcoma	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Nausea—Dactinomycin—sarcoma	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Agranulocytosis—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Pneumonia—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Etoposide—sarcoma	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Dizziness—Vincristine—sarcoma	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Infestation NOS—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Infestation—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Renal failure—Doxorubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Urticaria—Etoposide—sarcoma	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Haemoglobin—Epirubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Stomatitis—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Abdominal pain—Etoposide—sarcoma	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Body temperature increased—Etoposide—sarcoma	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Haemorrhage—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Vomiting—Vincristine—sarcoma	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Pharyngitis—Epirubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Epirubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Rash—Vincristine—sarcoma	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Dermatitis—Vincristine—sarcoma	0.00111	0.00111	CcSEcCtD
Gemifloxacin—Oedema peripheral—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Gemifloxacin—Haematuria—Doxorubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Gemifloxacin—Urethral disorder—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Gemifloxacin—Headache—Vincristine—sarcoma	0.00111	0.00111	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Vomiting—Mitoxantrone—sarcoma	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Visual impairment—Epirubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Agranulocytosis—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Rash—Mitoxantrone—sarcoma	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Dermatitis—Mitoxantrone—sarcoma	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Headache—Mitoxantrone—sarcoma	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Erythema multiforme—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Gemifloxacin—Eye disorder—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Gemifloxacin—Haemoglobin—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Nausea—Vincristine—sarcoma	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Flushing—Epirubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Cardiac disorder—Epirubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Haemorrhage—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Pharyngitis—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Oedema peripheral—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Asthenia—Etoposide—sarcoma	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Angiopathy—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Urethral disorder—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Nausea—Mitoxantrone—sarcoma	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Immune system disorder—Epirubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Epirubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Pruritus—Etoposide—sarcoma	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Visual impairment—Doxorubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Mental disorder—Epirubicin—sarcoma	0.000991	0.000991	CcSEcCtD
Gemifloxacin—Erythema multiforme—Doxorubicin—sarcoma	0.00099	0.00099	CcSEcCtD
Gemifloxacin—Diarrhoea—Etoposide—sarcoma	0.000981	0.000981	CcSEcCtD
Gemifloxacin—Eye disorder—Doxorubicin—sarcoma	0.000978	0.000978	CcSEcCtD
Gemifloxacin—Flushing—Doxorubicin—sarcoma	0.000971	0.000971	CcSEcCtD
Gemifloxacin—Cardiac disorder—Doxorubicin—sarcoma	0.000971	0.000971	CcSEcCtD
Gemifloxacin—Flatulence—Epirubicin—sarcoma	0.00097	0.00097	CcSEcCtD
Gemifloxacin—Tension—Epirubicin—sarcoma	0.000966	0.000966	CcSEcCtD
Gemifloxacin—Dysgeusia—Epirubicin—sarcoma	0.000964	0.000964	CcSEcCtD
Gemifloxacin—Nervousness—Epirubicin—sarcoma	0.000956	0.000956	CcSEcCtD
Gemifloxacin—Back pain—Epirubicin—sarcoma	0.000953	0.000953	CcSEcCtD
Gemifloxacin—Angiopathy—Doxorubicin—sarcoma	0.00095	0.00095	CcSEcCtD
Gemifloxacin—Dizziness—Etoposide—sarcoma	0.000948	0.000948	CcSEcCtD
Gemifloxacin—Muscle spasms—Epirubicin—sarcoma	0.000947	0.000947	CcSEcCtD
Gemifloxacin—Immune system disorder—Doxorubicin—sarcoma	0.000945	0.000945	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Doxorubicin—sarcoma	0.000943	0.000943	CcSEcCtD
Gemifloxacin—Mental disorder—Doxorubicin—sarcoma	0.000917	0.000917	CcSEcCtD
Gemifloxacin—Vomiting—Etoposide—sarcoma	0.000912	0.000912	CcSEcCtD
Gemifloxacin—Anaemia—Epirubicin—sarcoma	0.00091	0.00091	CcSEcCtD
Gemifloxacin—Rash—Etoposide—sarcoma	0.000904	0.000904	CcSEcCtD
Gemifloxacin—Dermatitis—Etoposide—sarcoma	0.000903	0.000903	CcSEcCtD
Gemifloxacin—Headache—Etoposide—sarcoma	0.000898	0.000898	CcSEcCtD
Gemifloxacin—Flatulence—Doxorubicin—sarcoma	0.000898	0.000898	CcSEcCtD
Gemifloxacin—Tension—Doxorubicin—sarcoma	0.000894	0.000894	CcSEcCtD
Gemifloxacin—Dysgeusia—Doxorubicin—sarcoma	0.000892	0.000892	CcSEcCtD
Gemifloxacin—Nervousness—Doxorubicin—sarcoma	0.000885	0.000885	CcSEcCtD
Gemifloxacin—Vertigo—Epirubicin—sarcoma	0.000885	0.000885	CcSEcCtD
Gemifloxacin—Syncope—Epirubicin—sarcoma	0.000883	0.000883	CcSEcCtD
Gemifloxacin—Leukopenia—Epirubicin—sarcoma	0.000882	0.000882	CcSEcCtD
Gemifloxacin—Back pain—Doxorubicin—sarcoma	0.000881	0.000881	CcSEcCtD
Gemifloxacin—Muscle spasms—Doxorubicin—sarcoma	0.000876	0.000876	CcSEcCtD
Gemifloxacin—Palpitations—Epirubicin—sarcoma	0.00087	0.00087	CcSEcCtD
Gemifloxacin—Loss of consciousness—Epirubicin—sarcoma	0.000866	0.000866	CcSEcCtD
Gemifloxacin—Nausea—Etoposide—sarcoma	0.000852	0.000852	CcSEcCtD
Gemifloxacin—Anaemia—Doxorubicin—sarcoma	0.000842	0.000842	CcSEcCtD
Gemifloxacin—Arthralgia—Epirubicin—sarcoma	0.000838	0.000838	CcSEcCtD
Gemifloxacin—Myalgia—Epirubicin—sarcoma	0.000838	0.000838	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000833	0.000833	CcSEcCtD
Gemifloxacin—Dry mouth—Epirubicin—sarcoma	0.00082	0.00082	CcSEcCtD
Gemifloxacin—Vertigo—Doxorubicin—sarcoma	0.000819	0.000819	CcSEcCtD
Gemifloxacin—Syncope—Doxorubicin—sarcoma	0.000817	0.000817	CcSEcCtD
Gemifloxacin—Leukopenia—Doxorubicin—sarcoma	0.000816	0.000816	CcSEcCtD
Gemifloxacin—Palpitations—Doxorubicin—sarcoma	0.000805	0.000805	CcSEcCtD
Gemifloxacin—Oedema—Epirubicin—sarcoma	0.000804	0.000804	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Epirubicin—sarcoma	0.000804	0.000804	CcSEcCtD
Gemifloxacin—Loss of consciousness—Doxorubicin—sarcoma	0.000801	0.000801	CcSEcCtD
Gemifloxacin—Shock—Epirubicin—sarcoma	0.000791	0.000791	CcSEcCtD
Gemifloxacin—Nervous system disorder—Epirubicin—sarcoma	0.000788	0.000788	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Epirubicin—sarcoma	0.000787	0.000787	CcSEcCtD
Gemifloxacin—Tachycardia—Epirubicin—sarcoma	0.000784	0.000784	CcSEcCtD
Gemifloxacin—Skin disorder—Epirubicin—sarcoma	0.000781	0.000781	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Epirubicin—sarcoma	0.000777	0.000777	CcSEcCtD
Gemifloxacin—Arthralgia—Doxorubicin—sarcoma	0.000776	0.000776	CcSEcCtD
Gemifloxacin—Myalgia—Doxorubicin—sarcoma	0.000776	0.000776	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00077	0.00077	CcSEcCtD
Gemifloxacin—Anorexia—Epirubicin—sarcoma	0.000766	0.000766	CcSEcCtD
Gemifloxacin—Dry mouth—Doxorubicin—sarcoma	0.000759	0.000759	CcSEcCtD
Gemifloxacin—Oedema—Doxorubicin—sarcoma	0.000744	0.000744	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Doxorubicin—sarcoma	0.000744	0.000744	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000732	0.000732	CcSEcCtD
Gemifloxacin—Shock—Doxorubicin—sarcoma	0.000732	0.000732	CcSEcCtD
Gemifloxacin—Nervous system disorder—Doxorubicin—sarcoma	0.000729	0.000729	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Doxorubicin—sarcoma	0.000728	0.000728	CcSEcCtD
Gemifloxacin—Insomnia—Epirubicin—sarcoma	0.000727	0.000727	CcSEcCtD
Gemifloxacin—Tachycardia—Doxorubicin—sarcoma	0.000726	0.000726	CcSEcCtD
Gemifloxacin—Skin disorder—Doxorubicin—sarcoma	0.000722	0.000722	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Doxorubicin—sarcoma	0.000719	0.000719	CcSEcCtD
Gemifloxacin—Dyspnoea—Epirubicin—sarcoma	0.000717	0.000717	CcSEcCtD
Gemifloxacin—Somnolence—Epirubicin—sarcoma	0.000715	0.000715	CcSEcCtD
Gemifloxacin—Anorexia—Doxorubicin—sarcoma	0.000709	0.000709	CcSEcCtD
Gemifloxacin—Dyspepsia—Epirubicin—sarcoma	0.000707	0.000707	CcSEcCtD
Gemifloxacin—Decreased appetite—Epirubicin—sarcoma	0.000699	0.000699	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000694	0.000694	CcSEcCtD
Gemifloxacin—Fatigue—Epirubicin—sarcoma	0.000693	0.000693	CcSEcCtD
Gemifloxacin—Pain—Epirubicin—sarcoma	0.000687	0.000687	CcSEcCtD
Gemifloxacin—Constipation—Epirubicin—sarcoma	0.000687	0.000687	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000678	0.000678	CcSEcCtD
Gemifloxacin—Insomnia—Doxorubicin—sarcoma	0.000673	0.000673	CcSEcCtD
Gemifloxacin—Dyspnoea—Doxorubicin—sarcoma	0.000663	0.000663	CcSEcCtD
Gemifloxacin—Somnolence—Doxorubicin—sarcoma	0.000661	0.000661	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Epirubicin—sarcoma	0.000657	0.000657	CcSEcCtD
Gemifloxacin—Dyspepsia—Doxorubicin—sarcoma	0.000655	0.000655	CcSEcCtD
Gemifloxacin—Decreased appetite—Doxorubicin—sarcoma	0.000646	0.000646	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000642	0.000642	CcSEcCtD
Gemifloxacin—Fatigue—Doxorubicin—sarcoma	0.000641	0.000641	CcSEcCtD
Gemifloxacin—Urticaria—Epirubicin—sarcoma	0.000638	0.000638	CcSEcCtD
Gemifloxacin—Constipation—Doxorubicin—sarcoma	0.000636	0.000636	CcSEcCtD
Gemifloxacin—Pain—Doxorubicin—sarcoma	0.000636	0.000636	CcSEcCtD
Gemifloxacin—Abdominal pain—Epirubicin—sarcoma	0.000635	0.000635	CcSEcCtD
Gemifloxacin—Body temperature increased—Epirubicin—sarcoma	0.000635	0.000635	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000608	0.000608	CcSEcCtD
Gemifloxacin—Urticaria—Doxorubicin—sarcoma	0.000591	0.000591	CcSEcCtD
Gemifloxacin—Body temperature increased—Doxorubicin—sarcoma	0.000588	0.000588	CcSEcCtD
Gemifloxacin—Abdominal pain—Doxorubicin—sarcoma	0.000588	0.000588	CcSEcCtD
Gemifloxacin—Asthenia—Epirubicin—sarcoma	0.000577	0.000577	CcSEcCtD
Gemifloxacin—Pruritus—Epirubicin—sarcoma	0.000569	0.000569	CcSEcCtD
Gemifloxacin—Diarrhoea—Epirubicin—sarcoma	0.00055	0.00055	CcSEcCtD
Gemifloxacin—Asthenia—Doxorubicin—sarcoma	0.000534	0.000534	CcSEcCtD
Gemifloxacin—Dizziness—Epirubicin—sarcoma	0.000531	0.000531	CcSEcCtD
Gemifloxacin—Pruritus—Doxorubicin—sarcoma	0.000526	0.000526	CcSEcCtD
Gemifloxacin—Vomiting—Epirubicin—sarcoma	0.000511	0.000511	CcSEcCtD
Gemifloxacin—Diarrhoea—Doxorubicin—sarcoma	0.000509	0.000509	CcSEcCtD
Gemifloxacin—Rash—Epirubicin—sarcoma	0.000507	0.000507	CcSEcCtD
Gemifloxacin—Dermatitis—Epirubicin—sarcoma	0.000506	0.000506	CcSEcCtD
Gemifloxacin—Headache—Epirubicin—sarcoma	0.000504	0.000504	CcSEcCtD
Gemifloxacin—Dizziness—Doxorubicin—sarcoma	0.000492	0.000492	CcSEcCtD
Gemifloxacin—Nausea—Epirubicin—sarcoma	0.000477	0.000477	CcSEcCtD
Gemifloxacin—Vomiting—Doxorubicin—sarcoma	0.000473	0.000473	CcSEcCtD
Gemifloxacin—Rash—Doxorubicin—sarcoma	0.000469	0.000469	CcSEcCtD
Gemifloxacin—Dermatitis—Doxorubicin—sarcoma	0.000468	0.000468	CcSEcCtD
Gemifloxacin—Headache—Doxorubicin—sarcoma	0.000466	0.000466	CcSEcCtD
Gemifloxacin—Nausea—Doxorubicin—sarcoma	0.000442	0.000442	CcSEcCtD
